PharmEasy becomes the latest victim of investors slashing valuations of indian startups

Janus Henderson and Neuberger Berman have marked down the valuation of PharmEasy's parent company API Holdings by half and 21%, respectively. This latest development adds PharmEasy to the growing list of Indian startups including BYJU's, Ola, Swiggy, among others, facing valuation markdowns. However, the company recently logged its first EBITDA profit and is aiming to become cash-positive by September. Will this be enough to keep investors interested?